XETRA - Delayed Quote EUR
Dow Inc. (2OY.DE)
26.60
-0.30
(-1.12%)
As of 10:47:24 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 15 | 16 |
| Avg. Estimate | 10.38B | 10.6B | 41.76B | 43.09B |
| Low Estimate | 10.32B | 10.23B | 40.64B | 40.61B |
| High Estimate | 10.47B | 10.9B | 42.36B | 44.87B |
| Year Ago Sales | 10.91B | 10.88B | 42.96B | 41.76B |
| Sales Growth (year/est) | -4.89% | -2.59% | -2.81% | 3.20% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2OY.DE | -- | -- | -- | -- |
| S&P 500 | 12.47% | 3.19% | 8.01% | 13.87% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 4/29/2025 |
| Upgrade | Fermium Research: Hold to Buy | 4/25/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/24/2025 |
| Downgrade | B of A Securities: Buy to Underperform | 4/15/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/9/2025 |
| Maintains | UBS: Neutral to Neutral | 4/7/2025 |